Iyuzeh
Payments companies reported to CMS as associated with Iyuzeh. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Iyuzeh, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Iyuzeh
These are the largest totals companies reported as associated with Iyuzeh. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Jason Bacharach | Petaluma, CA | Glaucoma Specialist | $40,090.75 |
| Michael Chaglasian | Chicago, IL | Optometrist | $23,311.41 |
| Aakriti Shukla | New York, NY | Ophthalmology | $21,352.65 |
| David Sola-Del Valle | Boston, MA | Ophthalmology | $21,064.40 |
| James Peace | Inglewood, CA | Retina Specialist | $10,238.83 |
| Joel Solano | Palm Desert, CA | Ophthalmology | $9,234.66 |
| Preeya Gupta | Raleigh, NC | Ophthalmology | $6,786.54 |
| Monique Barbour | Lake Worth Fl, FL | Ophthalmology | $6,479.78 |
| Joseph Panarelli | New York, NY | Ophthalmology | $4,875.00 |
| Sarah Vantassel | New York, NY | Glaucoma Specialist | $4,500.00 |
Prescribed Iyuzeh?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.